Translate

Tupac Amaru Shakur — “I'm Losing It… We MUST Unite!”

Where To Start

Start Here Start at 1619. Move forward.

The Arc is the spine of this project: 40 essays, one chronological argument, five analytical lenses.

The 40 Arc Essays — Canon Index → Full reading order · 1619 to the present · All 40 essays live

This site should read like a structured archive, not a loose category list. The Arc is the entry point; the lenses help you move through it with intention. Empty sections stay hidden until they are live.

Sunday, July 26, 2020

U.S. government gives Moderna Inc $472 million for coronavirus vaccine development

Moderna has received almost $1 billion dollars from the U.S. government for its coronavirus vaccine.

Moderna Inc., a biotech company that develops pharmaceuticals, received $472 million award from the federal Biomedical Advanced Research and Development Authority (BARDA).

This grant is in addition to the $483 million that was given to Moderna in April for their preliminary coronavirus vaccine research and development. That grant was from another U.S. federal agency that gives money to companies and organizations that work with disease-fighting technology.  

READ MORE: US signs contract with Pfizer for COVID-19 vaccine doses

Earlier this month, Moderna’s vaccine trials were delayed as the company wanted to change its study plan. Moderna says that this new grant will be used for clinical trails.

Moderna will be the first U.S. company to test their vaccine on humans.

“Encouraged by the Phase 1 data, we believe that our mRNA vaccine may aid in addressing the COVID-19 pandemic and preventing future outbreaks,” said StĂ©phane Bancel, chief executive officer, in a press release.

Moderna has been working on the coronavirus vaccine for months and has received almost $1 billion dollars from the government.

Dr. Stephen Hoge, president of Moderna, promised that the vaccine would not be sold at its production cost.

In mid-May, the U.S. Food and Drug Administration was given a “fast-track” designation. This would allow the new vaccine’s review to be expidited. This classification is only given to treatments and vaccines for serious ailments.

Moderna hopes to make a minimum of 500 million doses of their coronavirus vaccine available each year, starting in 2021.

READ MORE: U.K. coronavirus vaccine prompts immune response in early test

Moderna is based in Cambridge, Massachusetts and has been researching and creating “transformative medicines” for years.

”Its therapeutics and vaccine development programs span infectious diseases, oncology, cardiovascular diseases, and rare genetic diseases,” according to the company’s Reuters profile.

Have you subscribed to theGrio’s podcast “Dear Culture”? Download our newest episodes now!

The post U.S. government gives Moderna Inc $472 million for coronavirus vaccine development appeared first on TheGrio.



from TheGrio https://ift.tt/3f3tZkY